Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T20:42:37.706Z.
Calculation as of: 2026-10-06T20:42:37.706Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0b6e81bfb968b053e3c664bae947515aab5c23e1d2a9854177de48c3869b2902
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$4.83B
Price/OCF Ratio
N/A
TTM Avg
198.10
3Y Avg
199.02
5Y Avg
199.02
Market Cap
$4.78B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.73B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.70B
Price/OCF Ratio
21.58
TTM Avg
18.81
3Y Avg
169.88
5Y Avg
191.97
Market Cap
$4.64B
Price/OCF Ratio
13.39
TTM Avg
16.00
3Y Avg
16.81
5Y Avg
18.87
Market Cap
$5.06B
Price/OCF Ratio
17.28
TTM Avg
16.35
3Y Avg
45.96
5Y Avg
45.96
Market Cap
$5.07B
Price/OCF Ratio
17.90
TTM Avg
16.87
3Y Avg
25.21
5Y Avg
27.56
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | $4.84B | N/A | N/A | N/A | N/A |
| Mirum Pharmaceuticals, Inc. (MIRM)vs › | $4.83B | N/A | 198.10 | 199.02 | 199.02 |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.78B | N/A | N/A | N/A | N/A |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.73B | N/A | N/A | N/A | N/A |
| Erasca, Inc. (ERAS)vs › | $4.96B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 21.58 | 18.81 | 169.88 | 191.97 |
| Option Care Health, Inc. (OPCH)vs › | $4.64B | 13.39 | 16.00 | 16.81 | 18.87 |
| Waystar Holding Corp. (WAY)vs › | $5.06B | 17.28 | 16.35 | 45.96 | 45.96 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 17.90 | 16.87 | 25.21 | 27.56 |
| BillionToOne, Inc. (BLLN)vs › | $4.60B | 101.35 | 302.47 | 302.47 | 302.47 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
